Minnesota Lawmakers Plan Legislation to Regulate Private Equity Influence on Autism Therapy Providers
Following an investigation by The 74, two Minnesota state senators, Zaynab Mohamed and Scott Dibble, announced plans to seek legislation regulating the influence of private equity firms on autism therapy providers in Minneapolis-St. Paul. The proposed laws aim to increase…
Minneapolis St. Paul, MN, October 1, 2026 —
Two Minnesota state senators have announced their intention to introduce legislation aimed at regulating the involvement of private equity firms in autism therapy services, particularly in the Minneapolis-St. Paul area. The move follows an investigation conducted by The 74.
Senators Zaynab Mohamed and Scott Dibble are spearheading the legislative effort. Their proposed laws are designed to enhance transparency regarding the ownership structures of autism therapy providers. A key concern driving this initiative is the potential impact of profit-driven business models, often associated with private equity investments, on the quality of care delivered to autistic children.
Specifically, the legislation intends to address worries that the financial objectives of private equity owners could inadvertently compromise the effectiveness and standards of care for treatments such as Applied Behavior Analysis (ABA). ABA is a common therapeutic approach used for children diagnosed with autism spectrum disorder.
The specifics of the proposed legislation, including the exact mechanisms for increasing transparency and the penalties for non-compliance, were not detailed in the initial announcement. The contractor’s name for any related services was also not provided. The scope of the investigation by The 74 was also not elaborated upon in the provided summary.
The senators’ announcement signals a growing focus on the intersection of private investment and healthcare services, particularly those critical for vulnerable populations. The planned legislation seeks to strike a balance, ensuring that essential therapeutic services remain focused on patient well-being rather than solely on financial returns for external investors.
Further details regarding the timeline for introducing the legislation, the specific requirements for ownership disclosure, and any potential oversight bodies are expected to be released as the bill moves through the legislative process. The initiative aims to provide greater assurance to families that the autism therapies their children receive are of the highest quality and are not negatively influenced by the financial interests of private equity firms.
Story summarized from the original created by By Beth Hawkins, The 74 on www.minnpost.com, see more information here.
